Matisse Pharmaceuticals B.V.
Burg. Lemmensstraat 352, 6163 JT Geleen, The Netherlands
About the sponsor
Matisse Pharmaceuticals B.V. focuses its clinical research activity on critical care conditions related to sepsis and septic shock, with attention to the urgent medical needs associated with severe systemic infection and organ dysfunction.
- Critical care medicine
- Systemic inflammatory response
- Infection-related organ failure
The sponsor’s research interest is centered on therapies intended for acute hospital settings where rapid clinical intervention is required.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.
